This mirrors SSO‐QPOP analyses where the genetic ablation of CHK1 and BRD4 was identified as the most effective combination specific to MYC‐deregulated HCC, highlighting the translatability of SSO‐QPOP target prioritization in identifying clinically actionable targets and combinations. This evidence concerns the gene BRD4 and hepatocellular carcinoma.